JENNIFER RUIZ: Open Payments
NPI 1518732460 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,948 in 133 payments from 40 companies in 2025. Trend: 2023 $51 · 2024 $2,554 · 2025 $3,948
Food & beverage: $3,280Education: $493Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $392 |
| E.R. Squibb & Sons, L.L.C. | 7 | $314 |
| SEAGEN INC. | 3 | $294 |
| PFIZER INC. | 7 | $288 |
| Novartis Pharmaceuticals Corporation | 13 | $273 |
| Regeneron Healthcare Solutions, Inc. | 8 | $241 |
| AstraZeneca Pharmaceuticals LP | 9 | $210 |
| PUMA BIOTECHNOLOGY, INC. | 5 | $202 |
| Incyte Corporation | 9 | $200 |
| Merck Sharp & Dohme LLC | 8 | $191 |
Products named: RYBREVANT, LIBTAYO, OPDIVO, NERLYNX, KEYTRUDA, ELREXFIO, JAKAFI, XPOVIO.
Industry payments across IN — which companies pay providers there.
